文献速递骨肌MR

他汀类药物使用与大腿肌肉质量定量MRI生物标志物的纵向变化:来自骨关节炎倡议研究的数据

Statin use and longitudinal changes in quantitative MRI-based biomarkers of thigh muscle quality: data from Osteoarthritis Initiative.
PubMed 文献 · Skeletal Radiol · 2023-10-16

这项回顾性队列研究基于骨关节炎倡议研究数据,经1:1倾向评分匹配后纳入1910名参与者共3772侧大腿,使用经过验证的深度学习方法进行大腿肌肉MRI分割并计算肌肉质量生物标志物。结果显示,4年随访期间他汀使用与肌肉质量轻度下降相关,表现为膝伸最大力和特定收缩力降低、收缩百分比降低及肌内脂肪组织增加,分层分析显示这种变化仅见于无膝骨关节炎或存在膝骨关节炎风险的参与者,而已确诊膝骨关节炎者中未见此关联。

要点

  • 他汀使用与4年内膝伸最大力每年下降1.85 N及特定收缩力每年下降0.04 N/cm²相关。
  • 他汀使用与大腿肌肉收缩百分比每年下降0.03%及肌内脂肪组织每年增加3.06 mm²相关。
  • 肌肉质量下降仅见于无膝骨关节炎或存在膝骨关节炎风险的参与者,已确诊膝骨关节炎者中未见。

核心结论

  • 他汀使用与4年内基于MRI的大腿肌肉质量指标轻度下降相关;但考虑到他汀显著的心血管获益,这些轻微的肌肉变化在整体患者照护中可能相对不那么重要。

研究设计与样本

  • 回顾性队列研究,使用骨关节炎倡议研究数据,经1:1倾向评分匹配后纳入1910名参与者共3772侧大腿(他汀使用者1886侧,非使用者1886侧),年龄62±9岁(范围45-79岁),男女比例为1;使用经过验证的深度学习方法进行大腿肌肉MRI分割,在基线、第2次和第4次随访时计算肌肉质量生物标志物。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To assess whether changes in MRI-based measures of thigh muscle quality associated with statin use in participants with and without/at-risk of knee osteoarthritis.

METHODS: This retrospective cohort study used data from the Osteoarthritis Initiative study. Statin users and non-users were matched for relevant covariates using 1:1 propensity-score matching. Participants were further stratified according to baseline radiographic knee osteoarthritis status. We used a validated deep-learning method for thigh muscle MRI segmentation and calculation of muscle quality biomarkers at baseline, 2nd, and 4th visits. Mean difference and 95% confidence intervals (CI) in longitudinal 4-year measurements of muscle quality biomarkers, including cross-sectional area, intramuscular adipose tissue, contractile percent, and knee extensors and flexors maximum and specific contractile force (force/muscle area) were the outcomes of interest.

RESULTS: After matching, 3772 thighs of 1910 participants were included (1886 thighs of statin-users: 1886 of non-users; age: 62 ± 9 years (average ± standard deviation), range: 45-79; female/male: 1). During 4 years, statin use was associated with a slight decrease in muscle quality, indicated by decreased knee extension maximum (mean-difference, 95% CI: - 1.85 N/year, - 3.23 to - 0.47) and specific contractile force (- 0.04 N/cm2/year, - 0.07 to - 0.01), decreased thigh muscle contractile percent (- 0.03%/year, - 0.06 to - 0.01), and increased thigh intramuscular adipose tissue (3.06 mm2/year, 0.53 to 5.59). Stratified analyses showed decreased muscle quality only in participants without/at-risk of knee osteoarthritis but not those with established knee osteoarthritis.

CONCLUSIONS: Statin use is associated with a slight decrease in MRI-based measures of thigh muscle quality over 4 years. However, considering statins' substantial cardiovascular benefits, these slight muscle changes may be relatively less important in overall patient care.

来源:Skeletal Radiol,查看原文。版权归原作者所有。

引用

  1. Mohajer B, Moradi K, Guermazi A, et al. Statin use and longitudinal changes in quantitative MRI-based biomarkers of thigh muscle quality: data from Osteoarthritis Initiative. Skeletal Radiol. 2023. PMID: 37840051. doi:10.1007/s00256-023-04473-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。